Ireland to Ban Flavored E-Cigarettes, Advertising; Industry Warns 220,000 Vapers at Risk

Jun.03.2025
Ireland to Ban Flavored E-Cigarettes, Advertising; Industry Warns 220,000 Vapers at Risk
Ireland plans to ban flavored e-cigarettes, introduce plain packaging, and restrict in-store displays and advertising. The Responsible Vaping Ireland group warns the move could harm small businesses and reverse progress in reducing smoking. Since 2015, over 225,000 adults have quit smoking with e-cigarettes, making up nearly a quarter of quitters in 2023.

Key Points:

 

1.Ireland plans to ban flavored e-cigarettes and implement strict packaging and advertising restrictions.

 

2.E-cigarettes are seen as a tool to help people reduce smoking, with 225,000 people already successfully quitting smoking.

 

3.The Responsible E-Cigarette Association of Ireland is calling on the Health Minister and the Parliamentary Health Committee to conduct a thorough legislative review of the new bill.

 

4.A ban could lead to an increase in smoking rates, so the public health impacts of regulations should be carefully weighed.

 


 

According to recent reports from the Irish media outlet ShelfLife, the Irish government is planning to implement a comprehensive ban on e-cigarette products, including banning flavored e-cigarettes, introducing standardized packaging, and implementing a complete ban on in-store displays and advertising. This move has sparked strong concerns from the main industry association representing e-cigarette retailers in Ireland, Responsible Vaping Ireland (RVI).

 

The RVI has stated that the new legislation could have a devastating impact on small businesses, while adult smoking rates may also rebound. RVI is calling on Health Minister Jennifer Carroll MacNeill and the Parliamentary Health Committee to conduct a thorough legislative review and engage effectively with stakeholders before passing the new Public Health (Nicotine Inhaling Products) Bill 2025.

 

Data from Healthy Ireland shows the key role of e-cigarette products as smoking cessation tools. Since 2015, over 225,000 Irish adults have successfully quit smoking with the help of e-cigarettes. By 2023, nearly one in every four successful quitters in Ireland had used e-cigarettes to quit smoking, totaling over 23,000 people. Another study from the European School Survey Project on Alcohol and Other Drugs found that the lifetime prevalence of smoking has halved in the past 30 years, decreasing from 68% to 32%.

 

The RVI emphasized that major measures should undergo detailed scrutiny by parliamentary members before implementation, ensuring that the creation of new laws references the best international evidence. The RVI specifically noted that when the impact of regulations on reducing smoking rates is unclear, following due process is crucial. RVI spokesperson Lorraine Carolan stated on the eve of World No Tobacco Day that while we should reflect on Ireland's significant progress in reducing tobacco use, we must also acknowledge the role of e-cigarette products.

 

Carolyn concluded by saying:

 

"We fully support responsible regulation of the e-cigarette industry, but it is important to maintain a balance. Evidence shows that a blanket ban on e-cigarette products often does more harm than good."

 

RVI is calling on TDs and Senators on the Oireachtas Health Committee to thoroughly examine the bill and consult with stakeholders.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Indonesia's Ministry of Industry said at a November 3, 2026, policy forum that the country has about 200 electronic cigarette companies, Rp31 trillion (approximately $1.71 billion) in cumulative industry investment and around 100,000 jobs across the supply chain. The National Narcotics Agency is seeking a comprehensive ban on vape use and circulation, while the industry ministry favors tighter import, product-standard and distribution controls. Indonesia exported approximately $518 million in vaping products in 2025, and Chinese manufacturers including Smoore, GEEKVAPE and Jinjia Group have established local operations. An international logistics specialist interviewed by 2Firsts said more Chinese vape companies began production in Indonesia from the second half of 2025, accompanied by increased shipments of manufacturing equipment and investment in logistics facilities. The regulatory debate comes as Indonesia expands its role in international vaping manufacturing.
Special Report
Nov.05
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Extends Vape Rules to Unmanned Stores After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's Ministry of Gender Equality and Family said on September 14 that it plans to designate unmanned e-cigarette stores as businesses where minors are prohibited from entering or working. Operators would be required to verify customers' ages and display notices restricting access by minors. The proposal is open for public comment through October 6. The move follows an April expansion of South Korea's statutory tobacco definition that brought products made with natural or synthetic nicotine under the Tobacco Business Act. Nicotine-free liquids and products using nicotine analogues such as 6-methylnicotine, however, remain an emerging regulatory issue.
Sep.21
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10